Light therapy of late luteal phase dysphoric disorder: an extended study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8352356.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nineteen patients with late luteal phase dysphoric disorder (LLPDD) and 11 healthy comparison subjects underwent a 3-month crossover trial of bright (more than 2500 lux) white morning, bright white evening, and placebo dim (less than 10 lux) red evening light, administered daily for 1 week during the premenstrual phase of the menstrual cycle. All light treatments significantly reduced depressive ratings from baseline levels.
Medical subject headings
- Phototherapy
- Premenstrual Syndrome